Publications by authors named "J A Capriotti"

 The present study aimed to determine the average hip anthropometry of a regional Brazilian population using measurements based on computerized axial tomography (CAT).  Retrospective, descriptive analysis of hip measurements from 200 abdominal CATs from patients visiting a medical center. The tests were selected at random to determine 30 previously defined anthropometric measurements.

View Article and Find Full Text PDF

 In the present study, we investigated the intra and interobserver agreement of the new Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association (AO/OTA) classification for fractures of the proximal extremity of the femur.  One hundred hip radiographs were selected from patients who suffered fractures of the trochanteric region or femoral neck. Four orthopedists, fellowship trained hip surgeons, and four orthopedic residents evaluated and classified fractures according to the new AO/OTA system on two separate occasions.

View Article and Find Full Text PDF

Objectives: Femoroacetabular impingement (FAI) has been recently related to several pathologies, besides chondral injury and hip arthritis. We aim to investigate the prevalence of FAI morphology in an elderly cohort hospitalized due to a proximal femur fracture and compare these findings to a control group. We hypothesize that limited medial rotation due to FAI's morphology could increase stresses to the proximal femur, acting as a facilitating mechanism for fractures in this region.

View Article and Find Full Text PDF

Introduction: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the global pandemic of coronavirus disease 2019 (COVID-19). From the first reported cases in December 2019, the virus has spread to over 4 million people worldwide. Human-to-human transmission occurs mainly through the aerosolization of respiratory droplets.

View Article and Find Full Text PDF
Article Synopsis
  • Research evaluates nasal povidone-iodine (PVP-I) as a potential effective treatment against SARS-CoV-2, focusing on its ability to inactivate the virus in vitro at 15 and 30-second contact times.
  • The study tested three concentrations of PVP-I (0.5%, 1.25%, and 2.5%) against the virus and compared their efficacy to controls including ethanol and water.
  • Results showed that all tested PVP-I concentrations completely inactivated SARS-CoV-2 within 15 seconds, significantly outperforming the 70% ethanol control, which did not completely inactivate the virus at the same time.
View Article and Find Full Text PDF